Verition Fund Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$901K	Buy	+100,000	New	+$1.58M	0.01%	1354
2025 Q4	–	Sell	-27,179	Closed	-$398K	–	3469
2025 Q3	$398K	Sell	27,179 -24,528	-47%	-$420K	﹤0.01%	3148
2025 Q2	$942K	Buy	51,707 +2,349	+5%	+$47.9K	0.01%	2518
2025 Q1	$979K	Sell	49,358 -96,428	-66%	-$1.67M	0.01%	2141
2024 Q4	$2.5M	Sell	145,786 -199	-0.1%	-$3.74K	0.01%	1408
2024 Q3	$2.92M	Buy	145,985 +134,739	+1,198%	+$2.1M	0.02%	1185
2024 Q2	$126K	Buy	+11,246	New	+$94.3K	﹤0.01%	2698
2023 Q3	–	Sell	-707,028	Closed	-$2.61M	–	2307
2023 Q2	$2.61M	Buy	707,028 +393,890	+126%	+$1.46M	0.04%	562
2023 Q1	$1.04M	Sell	313,138 -261,920	-46%	-$905K	0.02%	931
2022 Q4	$2.23M	Sell	575,058 -794,494	-58%	-$2.45M	0.04%	581
2022 Q3	$3.33M	Buy	1,369,552 +1,344,560	+5,380%	+$3.23M	0.05%	621
2022 Q2	$49K	Sell	24,992 -1,276,646	-98%	-$2.51M	﹤0.01%	2149
2022 Q1	$2.38M	Buy	1,301,638 +797,749	+158%	+$1.24M	0.05%	843
2021 Q4	$710K	Buy	+503,889	New	+$662K	0.01%	1504